Half-year report · Q2
2689.TEDINET S100V7MJ
Period2024-07-01 → 2024-12-31
Filed2025-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥60.6bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥118.6bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥57.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥808m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥747m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥824m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥746m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥816m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥745m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥46.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥43.2bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥43.4bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥35.3bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥31.9bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥11.5bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.2bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥800m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥146m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥889m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥673m | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥347m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥109.44 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥251.68 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.01 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 24.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥67m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥19,000 |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥105m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥57.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥56.5bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥816m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥715m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥64m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥60.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥880m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥875m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥76m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥1m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥102m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥53.6bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥656m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥669m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥68m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥58.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥57.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥725m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥823m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 522
| Item | Context | Value | Unit |
|---|---|---|---|
| Treasury stock | Prior1YearInstant | -557173000 | JPY |
| Treasury stock | CurrentQuarterInstant | -551235000 | JPY |
| Shareholders equity | Prior1YearInstant | 10852922000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 10986632000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 162098000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 191309000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | － | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | -15807000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 358670000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 340123000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 520769000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 515625000 | JPY |
| Non controlling interests | Prior1YearInstant | － | JPY |
| Non controlling interests | CurrentQuarterInstant | － | JPY |
| Net assets | Prior1YearInstant | 11373691000 | JPY |
| Net assets | CurrentQuarterInstant | 11502258000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 43237194000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 46776191000 | JPY |
| Net sales | Prior1YTDDuration | 57466305000 | JPY |
| Net sales | CurrentYTDDuration | 60627694000 | JPY |
| Cost of sales | Prior1YTDDuration | 51035427000 | JPY |
| Cost of sales | CurrentYTDDuration | 53808117000 | JPY |
| Gross profit | Prior1YTDDuration | 6430878000 | JPY |
| Gross profit | CurrentYTDDuration | 6819577000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 5683979000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 6011456000 | JPY |
| Operating income | Prior1YTDDuration | 746899000 | JPY |
| Operating income | CurrentYTDDuration | 808120000 | JPY |
| Interest income noi | Prior1YTDDuration | 1119000 | JPY |
| Interest income noi | CurrentYTDDuration | 482000 | JPY |
| Dividends income noi | Prior1YTDDuration | 1056000 | JPY |
| Dividends income noi | CurrentYTDDuration | 1248000 | JPY |
| Insurance income noi | Prior1YTDDuration | 483000 | JPY |
| Insurance income noi | CurrentYTDDuration | 1939000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | － | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 15594000 | JPY |
| Gain on investments in partnership noi | Prior1YTDDuration | － | JPY |
| Gain on investments in partnership noi | CurrentYTDDuration | 6394000 | JPY |
| Commission fee noi | Prior1YTDDuration | 841000 | JPY |
| Commission fee noi | CurrentYTDDuration | 451000 | JPY |
| Electricity sale income noi | Prior1YTDDuration | 5130000 | JPY |
| Electricity sale income noi | CurrentYTDDuration | 4188000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 2895000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 2179000 | JPY |
| Other noi | Prior1YTDDuration | 7720000 | JPY |
| Other noi | CurrentYTDDuration | 5154000 | JPY |
| Non operating income | Prior1YTDDuration | 19246000 | JPY |
| Non operating income | CurrentYTDDuration | 37632000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 9798000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 16189000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |